31(top 2%)
papers
2.0K(top 1%)
citations
19(top 2%)
h-index
32(top 2%)
g-index
38
all documents
2.2K
doc citations
625
citing journals

Top Articles

#TitleJournalYearCitations
1Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialLancet, The2016771
2Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position StatementEndoscopy2017451
3The PROSIT-BIO CohortInflammatory Bowel Diseases2017116
4Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel DiseasesGastroenterology2018116
5Management of IBD during the COVID-19 outbreak: resetting clinical prioritiesNature Reviews Gastroenterology and Hepatology2020103
6Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn’s and Ulcerative Colitis Associations: Table 1.Journal of Crohn's and Colitis201787
7Cold snare endoscopic resection of nonpedunculated colorectal polyps larger than 10 mm: a systematic review and pooled-analysisGastrointestinal Endoscopy201982
8Risk of Colorectal Cancer and Cancer Related Mortality After Detection of Low-risk or High-risk Adenomas, Compared With No Adenoma, at Index Colonoscopy: A Systematic Review and Meta-analysisGastroenterology202145
9Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritisAlimentary Pharmacology and Therapeutics201743
10A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative ColitisJournal of Crohn's and Colitis202141
11Second-generation distal attachment cuff improves adenoma detection rate: meta-analysis of randomized controlled trialsGastrointestinal Endoscopy202137
12Drug development in IBD: from novel target identification to early clinical trialsGut201634
13Inflammatory Bowel Diseases and COVID-19: The Invisible EnemyGastroenterology202031
14Peroral endoscopic septotomy for short-septum Zenker’s diverticulumEndoscopy202029
15Diagnostic delay and misdiagnosis in eosinophilic oesophagitisDigestive and Liver Disease202128
16Preventing disability in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology201727
17Unmet Needs in IBD: the Case of FatigueClinical Reviews in Allergy and Immunology201825
18Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow‐up surveyUnited European Gastroenterology Journal201925
19The risk of liver cancer in autoimmune liver diseasesTherapeutic Advances in Medical Oncology201923
20Late-onset Crohn’s disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease ‘AGED’ studyEuropean Journal of Gastroenterology and Hepatology201914
21Filgotinib in Crohn’s Disease: JAK Is BackGastroenterology201712
22DOP10 Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudyJournal of Crohn's and Colitis202012
23Ustekinumab for treating ulcerative colitis: an expert opinionExpert Opinion on Biological Therapy202011
24Letter: immunogenicity of infliximab originator vs. CT‐P13 in IBD patientsAlimentary Pharmacology and Therapeutics20177
25Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaignDigestive and Liver Disease20207
26COVID-19 and endoscopic management of superficial gastrointestinal neoplastic lesions: a multinational cross-sectional surveyEndoscopy20217
27DOP13 Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trialJournal of Crohn's and Colitis20204
28New Drugs in the Ulcerative Colitis Pipeline: Prometheus UnboundGastroenterology20203
29P176 Expert consensus on acquisition and reporting of intestinal ultrasonography activity in Crohn’s disease. A prospective inter-rater agreement studyJournal of Crohn's and Colitis20203
30Effectiveness of Infliximab Biosimilar in Crohn’s Disease: A Dime, A DozenGastroenterology20192
31P271 Evolving Targets in Ulcerative colitis: Defining Disease Clearance in the VARSITY StudyJournal of Crohn's and Colitis20212
32DOP84 Early treatment responses within 14 days of intravenous vedolizumab induction therapy for Crohn’s Disease: Post hoc analysis of patient-reported outcomes from the VISIBLE 2 studyJournal of Crohn's and Colitis20210
33BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY20190
34THE NATURAL CLINICAL COURSE AFTER PER-ORAL ENDOSCOPIC MYOTOMY: IS MICROBIAL TRANSLOCATION THE KEY? A PROSPECTIVE RANDOMIZED CLINICAL TRIALEndoscopy20200
35MISS RATE DUE TO FAILURE RECOGNITION: ARTIFICIAL INTELLIGENCE ESTIMATE BASED ON A HIGH-QUALITY. A RANDOMIZED CLINICAL TRIAL20200
36Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION StudyZeitschrift Fur Gastroenterologie20210
37P09 Long-term obeticholic acid (OCA) for Primary Biliary Cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database20220